We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Stem Cell Based Treatment for Spinal Muscular Atrophy Receives Orphan Drug Designation

News   Dec 09, 2009

 
Stem Cell Based Treatment for Spinal Muscular Atrophy Receives Orphan Drug Designation
 
 
 

RELATED ARTICLES

Illegal CRISPR Baby Scientist Scandal: Second Woman Is Pregnant

News

An investigation into gene edited human babies was recently conducted by a special team from Guangdong province.

READ MORE

Stem Cells Grown in Media Free of Animal-derived Compounds

News

Research team finds that mesenchymal progenitors can be grown without use of animal-derived compounds, a requirement for therapeutic applications.

READ MORE

Genetics Reveal New Treatment Options for Osteoarthritis

News

In the largest genetic study of osteoarthritis to date, scientists have uncovered 52 new genetic changes linked to the disease, which doubles the number of genetic regions associated with the disabling condition.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE